Anosheh Afghahi, MD

Assistant Clinical Professor, Medicine-Medical Oncology


FacultyPhoto
Medical School
  • MD, Harvard Medical School (2009)
Graduate School
  • MPH, Harvard School of Public Health (2009)
Internship
  • Stanford Hospital and Clinics Program (2010)
Residency
  • Stanford Hospital and Clinics Program, Internal Medicine (2012)
Fellowships
  • Stanford Hospital and Clinics Program, Medical Oncology (2015)
Department
Medicine-Medical Oncology

Recognitions

  • Merit Award, ASCO-Conquer Cancer Foundation (2016)
  • Postdoctoral Fellowship Award, Susan G. Komen for the Cure (2015)
  • NIH Loan Repayment Program Award, NIH (2016)

Publications

  • Afghahi A, Timms KM, Vinayak S, Jensen KC, Kurian AW, Carlson RW, Chang P-J, Schackmann EA, Hartman A-R, Ford JM, Telli ML. Tumor BRCA1 Reversion Mutation Arising During Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer is Associated with Therapy Resistance. Clin Cancer Research, Jan 13, 2017.
  • Afghahi A, Telli ML, Kurian AK. Genetics of Triple-Negative Breast Cancer: Implications for Patient Care. Current Problems in Cancer. September 26, 2016.
  • Afghahi A, Mathur M, Thompson CA, Mitani A, Rigdon J, Desai M, Yu P, de Bruin M, Seto T, Olson C, Kenkare P, Gomez SL, Das AK, Luft HS, Sledge GW, Sing AP, and Kurian AW. Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Record, Cancer Registry and Genomic Data across Two Healthcare Systems. Journal of Oncology Practice Jun, 2016. PMID: 27221993.
  • Afghahi A, Kurian AW. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition. Current Treatment Options in Oncology. Accepted Jan 2017.
  • Afghahi A, Kurian AW. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition. Curr Treat Options Oncol. 2017 May;18(5):27. PubMed PMID: 28439798
  • Afghahi A, Timms KM, Vinayak S, Jensen KC, Kurian AW, Carlson RW, Chang PJ, Schackmann E, Hartman AR, Ford JM, Telli ML. Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance. Clin Cancer Res. 2017 Jul 1;23(13):3365-3370. PubMed PMID: 28087643
  • Afghahi A, Rigdon J, Purington N, Desai M, Pierson E, Mathur M, Thompson CA, Curtis C, West RB, Horst KC, Gomez SL, Ford JM, Sledge GW, Kurian AW. Higher peripheral lymphocyte count predicts survival in triple-negative breast cancer (TNBC). ASCO Meeting Abstract #1010 (Poster Discussion Session), 2016.
  • Marsh S, Borges VF, Coons HL, Afghahi A. Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers. Breast Cancer Res Treat. 2020 Dec;184(3):655-663. PubMed PMID: 32968951

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Lone Tree Medical Center
9548 Park Meadows Drive
Lone Tree, CO 80124
720-848-2200

UCHealth Diane O'Connor Thompson Breast Center - Anschutz
1635 Aurora Ct
3rd Floor
Aurora, CO 80045
720-848-1030

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Medical Oncology, Board Certification
  • Medical Oncology, Board Certification (2014)
  • Internal Medicine, Board Certification (2012)
Conditions & Treatments
  • Genetic Conditions and Testing
  • Cancers - Breast Cancer
  • Cancers
Clinical Interests
My clinical interest includes caring for patients and families with a personal or family history of breast and ovarian cancer.